Weekly journal scan: the KCa2 potassium channel as a promising target for the pharmacologic cardioversion of atrial fibrillation
Comment on the article ‘Inhibition of the KCa2 potassium channel in atrial fibrillation: a randomized phase 2 trial’, which was published in Nature Med; ht